-
Symbol
-
TRAW on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $.01 per share
-
Latest Disclosed Ownership
-
761K shares
-
Security Ownership
-
19.9%
Shares, Excluding Options vs Price
Value, Excluding Options
ORBIMED ADVISORS LLC ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW)
2025-01-29 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 761K shares of Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW).
This represents 19.9% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.